The next era of Greater Boston’s biotech boom
PharmaVoice
NOVEMBER 22, 2022
How Boston became the biotech capital of the U.S., and is now preparing for the next era of life sciences growth
Sat.Nov 19, 2022 - Fri.Nov 25, 2022
101 
Dental Health Plays Vital Role in Cardiovascular Well-Being
Pharmacy Times
NOVEMBER 21, 2022
Research also focuses on connection between oral hygiene and other chronic diseases, neurological disorders, pulmonary infections.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
How Clinical Trials Can Thrive in the Digital Era
PharmExec
NOVEMBER 22, 2022
The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.
Dr Frank Mathias
Pharmafile
NOVEMBER 23, 2022
Dr Frank Mathias has been appointed as life science firm Oxford Biomedica’s new CEO. Dr Mathias will take on his new role in March 2023, when he will replace Dr Roch Doliveux. The firm focuses on cell and gene therapies.
How bacteria-enabled technology for wounds could also help cancer patients
PharmaVoice
NOVEMBER 22, 2022
Evelina Vågesjö, co-founder and CEO of the immunotherapy company Ilya Pharma, is working on a new modality to speed wound healing
Gabapentin Presents High Potential for Misuse
Pharmacy Times
NOVEMBER 24, 2022
Although the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.
Tuning Into CTV - Real Time Data For Marketers
PharmExec
NOVEMBER 24, 2022
In episode 122, Marcella Milliet Sciorra, Chief Marketing Officer at DeepIntent, discusses Connected TV, or CTV, how it differs from over the top, and how CTV fits into the future of pharmaceutical marketing.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
In cancers with very low survival rates, Sellas aims higher
PharmaVoice
NOVEMBER 21, 2022
The company hopes its drugs can “take over where other available treatments fail” in multiple types of cancer
Workplace Stress Was Highest Among Younger Employees During COVID-19 Pandemic
Pharmacy Times
NOVEMBER 23, 2022
Study finds early career workers were more likely to disengage during the pandemic, such as by showing a lack of interest or becoming cynical about work.
Exploring the “Other” End-User – HCPs and the Challenges to Adoption of Machine Learning-based Digital Solutions
PharmExec
NOVEMBER 21, 2022
Webinar Date/Time: Mon, Dec 5, 2022 2:00 PM EST. us
FDA approves first gene therapy for Haemophilia B
European Pharmaceutical Review
NOVEMBER 23, 2022
The US Food and Drug Administration (FDA) has approved Hemgenix (etranacogene dezaparvovec), the first gene therapy for adults with Haemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening haemorrhage, or have repeated, serious spontaneous bleeding episodes.
Why the biopharma ‘IPO playbook’ changed in 2022
PharmaVoice
NOVEMBER 21, 2022
Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound
Improve Pain Management With Precision Pharmacotherapy
Pharmacy Times
NOVEMBER 25, 2022
Leveraging pharmacogenomic testing, simultaneous multidrug analysis can help prevent drug interactions affecting pain management.
Bottom of the Funnel Conversion though EHR Marketing and its Role in an Omnichannel Strategy
PharmExec
NOVEMBER 21, 2022
Webinar Date/Time: Wed, Dec 7, 2022 2:00 PM EST. us
Taking the right forecasting approach for rare diseases
Pharma Phorum
NOVEMBER 25, 2022
There are approximately 7,000 different types of rare disease and researchers estimate that there are more than 300 million people worldwide living with such a condition, according to the National Institutes of Health (NIH).
Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line
Fierce Pharma
NOVEMBER 23, 2022
Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line. zbecker. Wed, 11/23/2022 - 10:10
Multiple SARS-CoV-2 Infections May Elevate Risk of Organ Failure, Death
Pharmacy Times
NOVEMBER 21, 2022
Individuals with COVID-19 reinfections were twice as likely to die and three times more likely to be hospitalized than those who did not have COVID-19 multiple times.
Google rolls out search features that aim to make it easier to sign up for Medicaid, Medicare
Fierce Healthcare
NOVEMBER 23, 2022
Google rolls out search features that aim to make it easier to sign up for Medicaid, Medicare. pminemyer. Wed, 11/23/2022 - 11:12
First-in-human gene therapy trial for major cardiac syndrome
European Pharmaceutical Review
NOVEMBER 21, 2022
The first-in-human gene therapy trial for heart failure patients with preserved ejection fraction (HFpEF) has been approved by the US Food & Drug Administration (FDA).
On a roll, Takeda's dengue vaccine shifts into FDA's fast review lane
Fierce Pharma
NOVEMBER 23, 2022
On a roll, Takeda's dengue vaccine shifts into FDA's fast review lane. kdunleavy. Wed, 11/23/2022 - 09:35
Kidney Damage From Diabetes Worsens Over Time
Pharmacy Times
NOVEMBER 25, 2022
Pharmacists play a significant role in the comprehensive management of this condition through education, intervention, and monitoring.
Walgreens plots 'aggressive' strategy to build out healthcare services, CEO Roz Brewer says
Fierce Healthcare
NOVEMBER 20, 2022
Walgreens plots 'aggressive' strategy to build out healthcare services, CEO Roz Brewer says. hlandi. Sun, 11/20/2022 - 18:20
Ex-Theranos CEO Elizabeth Holmes sentenced to 11 years
Pharma Phorum
NOVEMBER 20, 2022
Elizabeth Holmes, the founder and former chief executive of blood testing biotech Theranos, has been sentenced after being convicted of defrauding investors in the company earlier this year, receiving a prison sentence of more than 11 years in a California court.
Senator aims to cut biosimilar 'red tape' with proposal to eliminate interchangeable status
Fierce Pharma
NOVEMBER 23, 2022
Senator aims to cut biosimilar 'red tape' with proposal to eliminate interchangeable status. kdunleavy. Wed, 11/23/2022 - 07:18
Alzheimer Law Allows Younger Patients to Gain Eligibility for Grants, Programs
Pharmacy Times
NOVEMBER 24, 2022
Legislation expands protection of original 1965 act to individuals younger than 60 years.
Iveda reveals AI-driven caregiver assistant, IvedaCare
Pharmafile
NOVEMBER 24, 2022
Iveda, a US-based technology company, has introduced their new cloud-based artificial intelligence (AI) assistant called IvedaCare. The company says they have designed the at-home AI caregiver for ‘safety, security, and elderly care.’. read more. Business Services
Advocacy groups press FTC to probe GPOs' role in supply chain shortages
Fierce Healthcare
NOVEMBER 22, 2022
Advocacy groups press FTC to probe GPOs' role in supply chain shortages. rking. Tue, 11/22/2022 - 16:21
J&J's nasal spray Spravato bests former AZ drug Seroquel XR in treatment-resistant depression trial
Fierce Pharma
NOVEMBER 23, 2022
J&J's nasal spray Spravato bests former AZ drug Seroquel XR in treatment-resistant depression trial. fkansteiner. Wed, 11/23/2022 - 09:26
Locking Prescription Vials Helps Keep Medicine Safe in Medication-assisted Treatment Programs
Pharmacy Times
NOVEMBER 23, 2022
For patients with opioid use disorder, medication-assisted treatment programs are a clinically effective approach.
Haemophilia drug costing $3.5m per dose has been approved
Pharmafile
NOVEMBER 23, 2022
CSL Behring’s haemophilia B gene therapy has recently been approved by US regulators, however the treatment has an enormous price tag. Costing $3.5m per dose, the one-off infusion therapy has become the world’s most expensive medicine currently available.
Provention prices type 1 diabetes drug Tzield at $194,000
Pharma Phorum
NOVEMBER 21, 2022
Provention Bio has priced its new type 1 diabetes (T1D) prevention therapy Tzield at $13,850 per vial – equivalent to almost $194,000 for its 14-day course – a higher level than had been predicted by industry observers.
Ozempic compensating for Wegovy’s supply shortage due to high demand
Pharmaceutical Technology
NOVEMBER 25, 2022
In recent months, Wegovy (semaglutide), indicated for obesity, has been subjected to widespread supply shortages due to high demand, in addition to manufacturer production problems, with Novo Nordisk intending to relaunch Wegovy by the end of 2022.
5 Hot Topics for Community Pharmacists in 2023
Pharmacy Times
NOVEMBER 23, 2022
As a new year approaches, pharmacists have so much to look back on and be grateful for, and a world of opportunity in front of them. Here are a few things to be ready for right away in 2023.
Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits
Fierce Pharma
NOVEMBER 23, 2022
Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits. fkansteiner. Wed, 11/23/2022 - 08:05
Why should pharma invest in digital products for those living with rare diseases?
Pharma Phorum
NOVEMBER 23, 2022
Each person living with a rare disease has a unique experience of their condition, but all will have faced similar challenges.
NICE questions value and efficacy of five Covid-19 drugs with rejection
Pharmaceutical Technology
NOVEMBER 20, 2022
The UK's National Institute for Health and Care Excellence (NICE) has published a draft guidance that does not recommend the use of five major Covid-19 therapies.
New Tool Developed to Track How Breast Cancer Grows
Pharmacy Times
NOVEMBER 21, 2022
New system combines computational and experimental techniques to map evolutionary cancer lineages in their natural habitat of human tissue.
Let's personalize your content